Male sexual dysfunction is common in chronic kidney disease, particularly in end-stage
renal disease. Historically this cause of considerable morbidity has been under-reported …

Introduction Phosphodiesterase type 5 inhibitors (PDE5Is) have demonstrated efficacy in the
treatment of erectile dysfunction (ED). Although historically found to have limited drug …

Introduction Currently in the medical literature there is controversy about the role and effects
of renal transplantation (RTx) on the sexual functioning of patients with terminal chronic …

Erectile dysfunction (ED) is a major global health burden commonly observed in patients
with end-stage renal disease (ESRD). Although renal transplantation improves the problem …

BACKGROUND: Effects of renal transplantation (RT) on erectile dysfunction (ED) is a
controversial issue. OBJECTIVE: To verify the efficacy of RT in restoring erectile function …

Abstract The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice
guideline on the monitoring, management, and treatment of kidney transplant recipients is …

Objectives Sexual dysfunction occurs commonly in individuals with end-stage renal disease.
Chronic renal failure as well as the treatments used for it generally has a negative impact on …

Purpose: Erectile dysfunction has a lower prevalence in renal transplant recipients
compared to dialysis patients. Despite this observation, the effect of renal transplantation on …

Introduction Kidney and simultaneous pancreas kidney (SPK) transplant recipients are
younger and fitter than most other dialysis patients, but are also more vulnerable in areas of …

Objective. Many patients experience problems with sexual functioning after renal
transplantation (RTx). Research on the sexual functioning of the partners of those patients …